BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 137 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,000 | -98.0% | 200 | -99.2% | 0.00% | -100.0% |
| Q1 2020 | $49,000 | +250.0% | 24,433 | +581.2% | 0.00% | +200.0% |
| Q2 2019 | $14,000 | +40.0% | 3,587 | +172.2% | 0.00% | 0.0% |
| Q3 2018 | $10,000 | +42.9% | 1,318 | +64.8% | 0.00% | 0.0% |
| Q1 2017 | $7,000 | -90.0% | 800 | -96.8% | 0.00% | -90.0% |
| Q2 2016 | $70,000 | +311.8% | 24,700 | +311.7% | 0.01% | +400.0% |
| Q1 2016 | $17,000 | +142.9% | 6,000 | +650.0% | 0.00% | +100.0% |
| Q1 2015 | $7,000 | -87.3% | 800 | -82.2% | 0.00% | -87.5% |
| Q4 2014 | $55,000 | +71.9% | 4,500 | +36.4% | 0.01% | +60.0% |
| Q3 2014 | $32,000 | -3.0% | 3,300 | +26.9% | 0.01% | +25.0% |
| Q2 2014 | $33,000 | – | 2,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 1,744,356 | $18,455,000 | 9.59% |
| RA Capital Management | 4,347,456 | $45,996,000 | 3.30% |
| Cormorant Asset Management, LP | 1,168,000 | $12,357,000 | 2.84% |
| Baker Brothers Advisors | 5,867,031 | $62,073,000 | 0.79% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 907,920 | $9,606,000 | 0.39% |
| QVT Financial LP | 525,734 | $5,562,000 | 0.32% |
| EAM Investors, LLC | 114,548 | $1,212,000 | 0.22% |
| FRANKLIN STREET ADVISORS INC /NC | 93,000 | $984,000 | 0.20% |
| THB ASSET MANAGEMENT | 301,529 | $3,190,000 | 0.19% |
| TPG Group Holdings (SBS) Advisors, Inc. | 1,162,269 | $12,297,000 | 0.13% |